Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
ZEB1 transcription factor promotes immune escape in melanoma.
J Immunother Cancer. 2022 Mar;10(3):e003484. doi: 10.1136/jitc-2021-003484.
J Immunother Cancer. 2022.
PMID: 35288462
Free PMC article.
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma.
Benboubker V, Boivin F, Dalle S, Caramel J.
Benboubker V, et al.
Front Immunol. 2022 Mar 29;13:873116. doi: 10.3389/fimmu.2022.873116. eCollection 2022.
Front Immunol. 2022.
PMID: 35432344
Free PMC article.
Review.
Item in Clipboard
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
Rouanet J, Benboubker V, Akil H, Hennino A, Auzeloux P, Besse S, Pereira B, Delorme S, Mansard S, D'Incan M, Degoul F, Rouzaire PO.
Rouanet J, et al. Among authors: benboubker v.
Cancer Immunol Immunother. 2020 Oct;69(10):2075-2088. doi: 10.1007/s00262-020-02606-8. Epub 2020 May 23.
Cancer Immunol Immunother. 2020.
PMID: 32447411
Free PMC article.
Item in Clipboard
ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
Durand S, Tang Y, Pommier RM, Benboubker V, Grimont M, Boivin F, Barbollat-Boutrand L, Cumunel E, Dupeuble F, Eberhardt A, Plaschka M, Dalle S, Caramel J.
Durand S, et al. Among authors: benboubker v.
Oncogene. 2024 Mar 22. doi: 10.1038/s41388-024-03010-7. Online ahead of print.
Oncogene. 2024.
PMID: 38519642
Item in Clipboard
Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.
Akil H, Quintana M, Raymond JH, Billoux T, Benboubker V, Besse S, Auzeloux P, Delmas V, Petit V, Larue L, D'Incan M, Degoul F, Rouanet J.
Akil H, et al. Among authors: benboubker v.
Cancers (Basel). 2021 Mar 20;13(6):1421. doi: 10.3390/cancers13061421.
Cancers (Basel). 2021.
PMID: 33804655
Free PMC article.
Item in Clipboard
Cite
Cite